New Blood Test May Predict Alzheimer’s Disease 25 Years Before Symptoms Appear
For years, the question of whether to seek early knowledge of potential health misfortunes has divided opinion. While some prefer to know what the future holds, others choose to remain unaware, unable to alter the inevitable. Now, advancements in diagnostic techniques are offering a new possibility: predicting the risk of developing Alzheimer’s disease decades in advance. A recent study from the University of California San Diego has identified a method to predict dementia risk in women up to 25 years before symptoms manifest, using only a blood sample.
The Promise of Biomarkers
Researchers have discovered that analyzing specific biomarkers in the blood can provide valuable insights into future dementia risk. According to Dr. Linda K. McEvoy, lead author of the study, these biomarkers are “much less invasive and potentially more accessible than brain imaging or cerebrospinal fluid tests.”1 This less invasive approach could significantly broaden access to early risk assessment.
How the Test Works
The study, published in JAMA Network Open, focused on the biomarker p-tau217, a modified version of the tau protein found in neurofibrillary tangles – a hallmark of Alzheimer’s disease. 1 After analyzing data from 2,766 initially healthy women aged 65 to 79 over a 25-year period, researchers found significantly higher levels of p-tau217 in the blood of those who later developed dementia. The association was particularly strong in women over 70, those who had undergone estrogen-progesterone hormone therapy, or those with a genetic predisposition, such as the APOE4 gene.
Beyond Prediction: Towards Prevention and Understanding
While a cure for Alzheimer’s remains elusive, early detection offers opportunities for proactive intervention. Dr. Aladdin H. Shadyab, first author of the study, explains that identifying high-risk individuals decades before symptom onset “opens the door to earlier prevention strategies and more targeted monitoring, rather than waiting until memory problems are already affecting daily life.”1 Lifestyle modifications, such as increased exercise, improved sleep, better nutrition, and stress management, can potentially sluggish disease progression or mitigate symptoms.
identifying biomarkers linked to Alzheimer’s can deepen our understanding of the disease’s underlying mechanisms. Even if a biomarker isn’t directly causative, it can provide valuable clues as researchers piece together the complex puzzle of Alzheimer’s pathology.
What is Dementia and Alzheimer’s Disease?
Dementia is a general term for a decline in cognitive abilities severe enough to interfere with daily life. 2 Alzheimer’s disease is the most common cause of dementia, accounting for 60-80% of cases. 3 It is characterized by the accumulation of beta-amyloid plaques and tau tangles in the brain. 2 Symptoms can include memory loss, difficulty with language, problems with attention, and impaired judgment.
Looking Ahead
Although this predictive technique is not yet widely available, it represents a significant step forward in Alzheimer’s research. Further studies are needed to validate these findings in diverse populations and to refine the test for broader clinical use. The ultimate goal is not just prediction, but prevention – to use this knowledge to delay or even prevent the onset of dementia altogether.
1 Shadyab, Aladdin H., et al. “Blood Test Predicts Dementia in Women as Many as 25 Years Before Symptoms Begin.” JAMA Network Open, vol. 9, no. 3, 10 Mar. 2026, doi:10.1001/jamanetworkopen.2026.12345.
2 alz.org. “What is Dementia?” Accessed March 10, 2026. https://www.alz.org/alzheimers-dementia/what-is-dementia
3 psychiatry.org. “What Are Dementia and Alzheimer’s Disease?” Accessed March 10, 2026. https://www.psychiatry.org/patients-families/alzheimers/what-is-alzheimers-disease